A5018644288- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease Diagnosis and Treatment
- MRI in cancer diagnosis
- Liver Disease and Transplantation
- Radiomics and Machine Learning in Medical Imaging
- Hepatitis C virus research
- Ultrasound in Clinical Applications
- COVID-19 diagnosis using AI
- Cancer, Lipids, and Metabolism
- COVID-19 Clinical Research Studies
- Gallbladder and Bile Duct Disorders
- Pancreatic and Hepatic Oncology Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Surgical Treatments
- Advanced MRI Techniques and Applications
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pediatric Hepatobiliary Diseases and Treatments
- Atomic and Subatomic Physics Research
- Multiple and Secondary Primary Cancers
- Lung Cancer Treatments and Mutations
- Liver physiology and pathology
- Skin Protection and Aging
- Hepatitis B Virus Studies
Policlinico S.Orsola-Malpighi
2013-2024
University of Ferrara
2024
Istituti di Ricovero e Cura a Carattere Scientifico
2024
Azienda USL di Bologna
2022-2023
Arcispedale Sant'Anna
2021-2022
University of Milano-Bicocca
2017-2021
Azienda Ospedaliera San Gerardo
2018-2021
University of Bologna
2012-2018
Ospedale Papa Giovanni XXIII
2016-2018
Medica (Italy)
2014
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome and may evolve into hepatocellular carcinoma (HCC). Only scanty clinical information is available on HCC in NAFLD. The aim this multicenter observational prospective study was to assess features patients with NAFLD-related (NAFLD-HCC) compare them those hepatitis C virus (HCV)-related HCC. A total 756 either NAFLD (145) or HCV-related chronic (611) were enrolled secondary care Italian centers....
The prognosis of untreated patients with hepatocellular carcinoma (HCC) is heterogeneous, and survival data were mainly obtained from control arms randomized studies. Clinical practice on this topic are urgently needed, so as to help plan studies counsel patients. We assessed the 600 HCC managed by Italian Liver Cancer Group. Prognosis was evaluated subdividing according Barcelona Clinic (BCLC) classification. also main demographic, clinical, oncological determinants in subgroup advanced...
Portal vein thrombosis (PVT) is a frequent complication of cirrhosis. Benefit, safety, and duration anticoagulant treatment in this setting are controversial issues. The aim study was to analyze the course PVT large cohort cirrhotic patients undergoing or not anticoagulation therapy.The data 182 who presented between January 2008 March 2016 with cirrhosis at least 3 months follow-up after first detection were analyzed. Eighty-one received anticoagulants 101 untreated per physician...
BACKGROUND α‐Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular carcinoma (HCC), although possible determinants its serum levels these have not been adequately explored. For this study, authors evaluated relevance demographic, clinical, and oncologic factors to presence elevated AFP large cohort HCC. METHODS In 4123 HCC who were managed by Italian Liver Cancer Group, assessed along their association biochemical, characteristics. Patients...
Abstract Background & Aims The Barcelona Clinic Liver Cancer intermediate stage ( BCLC ‐B) of hepatocellular carcinoma HCC ) includes extremely heterogeneous patients in terms tumour burden and liver function. Transarterial‐chemoembolization TACE is the first‐line treatment for these although it may be risky/useless someone, while others could undergo curative treatments. This study assesses type performed a large cohort ‐B its outcome. Methods Retrospective analysis 485 consecutive from...
Background: The aim of the present study is to determine feasibility biopsy for atypical liver nodules in patients under surveillance hepatocellular carcinoma (HCC), assessing which factors influence decision perform it. Methods: A total 128 108 HCC, who underwent CT between September 2018 and 2019, were included. All images saved digitally (on CD-ROM) two most representative arterial delayed phases selected each lesion inserted into a digital atlas PDF). Two experienced radiologists...
To evaluate the diagnostic accuracy and imaging features of routine admission chest X-ray in patients suspected for novel Coronavirus 2019 (SARS-CoV-2) infection.
Abstract Objectives To evaluate a semi-automated segmentation and ventilated lung quantification on chest computed tomography (CT) to assess involvement in patients affected by SARS-CoV-2. Results were compared with clinical functional parameters outcomes. Methods All images underwent quantitative analyses dedicated workstation using semi-automatic software compute volume (VLV), Ground-glass opacity (GGO) (GGO-V), consolidation (CONS-V) as absolute percentage of total (TLV). The ratio...
Background: To evaluate the segmental distribution of hepatocellular carcinoma (HCC) according to Couinaud’s anatomical division in cirrhotic patients. Methods: Between 2020 and 2021, a total 322 HCC nodules were diagnosed 217 patients who underwent computed tomography (CT) or magnetic resonance imaging (MRI) for evaluation suspicious (>1 cm) detected during ultrasound surveillance. For each patient, position nodule was recorded description. The clinical data characteristics collected....
Abstract Background & Aims Hepatitis C virus ( HCV ) is the leading aetiological factor of HCC in western world where, overall, its incidence increasing, despite data suggesting an initial drop some areas. The aim this study was to evaluate epidemiology, clinical features and survival ‐related ‐ a wide time range I taly. Methods Multicentre retrospective including 3695 patients prospectively recruited by ITA . LI CA group. Patients were classified into three subgroups according aetiology...
Malignancies are generally considered a risk factor for deep vein thrombosis and may hamper the recanalisation of thrombosed veins.We investigate whether natural course response to anticoagulant treatment bland portal (PVT) in patients with cirrhosis complicated by hepatocellular carcinoma (HCC) differ from those without HCC.Retrospective study two hepatology referral centres, Italy Romania where diagnosis PVT on follow-up at least 3 months repeated imaging were included.A total 162 matching...